DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 13.76%3.65B | -4.52%957M | 49.21%1.26B | 25.52%801.7M | -12.89%626.6M | 1.11%3.21B | 4.69%1B | -6.91%845.4M | 22.87%638.7M | -8.39%719.3M |
Net income from continuing operations | 67.57%3.84B | 186.60%1.96B | 16.96%696.6M | 30.15%572.4M | 6.48%609.3M | 2.20%2.29B | 20.11%685.2M | 2.32%595.6M | -17.10%439.8M | 2.11%572.2M |
Operating gains losses | -5,319.75%-1.76B | -1,075.44%-1.67B | -105.75%-11M | 62.33%-36.5M | -387.92%-42.9M | 80.38%-32.4M | -444.77%-141.7M | 2,889.06%191.3M | -2.54%-96.9M | 112.62%14.9M |
Depreciation and amortization | 6.83%1.45B | 6.58%380.8M | 6.00%360.3M | 6.24%360.8M | 8.62%349.2M | 1.50%1.36B | 7.36%357.3M | 0.80%339.9M | 1.10%339.6M | -3.25%321.5M |
Deferred tax | -180.57%-69.3M | 147.17%5M | -88.40%-81.2M | -143.42%-6.6M | -2.17%13.5M | -176.47%-24.7M | 71.12%-10.6M | -343.50%-43.1M | -57.30%15.2M | -12.10%13.8M |
Other non cash items | 1,382.05%300M | 186.39%204.4M | -71.89%28.9M | 267.50%13.4M | -54.98%53.3M | 88.90%-23.4M | -72.45%-236.6M | 719.28%102.8M | 72.88%-8M | 528.99%118.4M |
Change In working capital | 56.92%-183M | -84.16%53M | 247.03%250.1M | 53.71%-116.5M | -9.48%-369.6M | -266.84%-424.8M | 90.66%334.6M | -484.54%-170.1M | 6.40%-251.7M | -5,138.81%-337.6M |
-Change in receivables | -307.59%-76.6M | -180.50%-148.6M | 129.47%72.7M | -20.37%52M | -256.38%-52.7M | 107.74%36.9M | 386.20%184.6M | -10.53%-246.7M | 192.49%65.3M | 128.39%33.7M |
-Change in inventory | -6.49%-137.8M | -753.66%-26.8M | -80.66%-38.3M | -153.68%-24.1M | 52.72%-48.6M | -37.22%-129.4M | 130.37%4.1M | 9.79%-21.2M | 59.75%-9.5M | -205.04%-102.8M |
-Change in payables and accrued expense | -58.79%-338.7M | -200.93%-163.6M | 65.88%125.9M | 83.22%-32.5M | -4.23%-268.5M | -140.06%-213.3M | -23.68%162.1M | -61.47%75.9M | -335.28%-193.7M | -253.70%-257.6M |
-Change in other working capital | 411.01%370.1M | 2,519.75%392M | 310.05%89.8M | 1.67%-111.9M | 101.83%200K | -54.55%-119M | -139.42%-16.2M | 6.31%21.9M | 12.60%-113.8M | -28.24%-10.9M |
Cash from discontinued investing activities | 0 | -98.99%600K | ||||||||
Operating cash flow | 13.74%3.65B | -4.58%957M | 49.21%1.26B | 25.52%801.7M | -12.89%626.6M | -0.74%3.21B | -1.39%1B | -6.91%845.4M | 22.87%638.7M | -8.39%719.3M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 16.85%-4.92B | 90.41%-145.4M | 19.54%-1.55B | 29.71%-1.56B | -550.12%-1.67B | -53.39%-5.92B | -49.70%-1.52B | -823.57%-1.92B | -142.15%-2.22B | 85.10%-256.2M |
Net PPE purchase and sale | -46.91%-6.8B | -41.86%-2.08B | -21.49%-1.61B | -65.80%-1.67B | -73.28%-1.45B | -58.09%-4.63B | -85.79%-1.46B | -87.44%-1.32B | -30.80%-1.01B | -25.67%-834.2M |
Net business purchase and sale | --0 | --0 | --0 | ---- | ---- | 47.08%-912M | --0 | --0 | ---- | ---- |
Net investment purchase and sale | 28.18%329.3M | 187.67%57.6M | 2,613.33%40.7M | 166.24%166.4M | -88.71%64.6M | -65.27%256.9M | 71.64%-65.7M | -99.69%1.5M | -105.06%-251.2M | -5.33%572.3M |
Net other investing changes | 343.85%1.55B | 15,501.67%1.87B | 103.00%18.1M | -15.49%-57.4M | -5,094.74%-284.7M | -1,293.42%-634.9M | -11.11%12M | -7,731.65%-602.9M | -304.53%-49.7M | -24.00%5.7M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 16.85%-4.92B | 90.41%-145.4M | 19.54%-1.55B | 29.71%-1.56B | -550.12%-1.67B | -53.39%-5.92B | -49.70%-1.52B | -823.57%-1.92B | -142.15%-2.22B | 85.10%-256.2M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 62.49%2.62B | -145.49%-232.3M | -72.71%135.2M | 95.89%1.35B | 1,692.06%1.36B | 260.86%1.61B | 370.93%510.7M | 1,969.81%495.5M | 443.64%689M | 85.37%-85.6M |
Net issuance payments of debt | 23.14%3.9B | -96.12%42.3M | -48.97%407.5M | 67.09%1.68B | 542.96%1.78B | 725.05%3.17B | 534.05%1.09B | 154.62%798.5M | 650.19%1B | 217.42%276.3M |
Cash dividends paid | -4.56%-1.56B | -1.23%-393.5M | -1.23%-393.5M | -8.12%-389M | -8.21%-388.9M | -8.19%-1.5B | -8.15%-388.7M | -8.21%-388.7M | -8.18%-359.8M | -8.22%-359.4M |
Proceeds from stock option exercised by employees | -67.08%7.9M | -62.22%1.7M | -79.17%500K | -87.10%400K | -62.14%5.3M | 24.35%24M | 50.00%4.5M | 26.32%2.4M | 181.82%3.1M | 5.26%14M |
Net other financing activities | 411.29%270.2M | 159.70%117.2M | 44.90%120.7M | 46.14%62.4M | -82.42%-30.1M | -319.32%-86.8M | -4,573.81%-196.3M | 384.30%83.3M | 1,681.48%42.7M | 46.77%-16.5M |
Cash from discontinued financing activities | 0 | 0 | ||||||||
Financing cash flow | 62.49%2.62B | -145.49%-232.3M | -72.71%135.2M | 95.89%1.35B | 1,692.06%1.36B | 260.86%1.61B | 370.93%510.7M | 1,969.81%495.5M | 443.64%689M | 85.37%-85.6M |
Net cash flow | ||||||||||
Beginning cash position | -40.35%1.62B | 45.06%2.38B | 13.05%2.54B | -37.32%1.96B | -40.35%1.62B | -39.34%2.71B | -44.62%1.64B | -4.53%2.24B | 6.00%3.13B | -39.34%2.71B |
Current changes in cash | 222.03%1.34B | 19,410.00%579.3M | 74.06%-151.2M | 166.25%591M | -14.23%323.8M | 32.39%-1.1B | 98.37%-3M | -186.56%-582.9M | -49.33%-892.1M | 124.85%377.5M |
Effect of exchange rate changes | 204.62%19.8M | 239.55%24.7M | 62.84%-8.1M | -631.43%-18.6M | -48.71%21.8M | 104.99%6.5M | 71.36%-17.7M | 66.31%-21.8M | 146.05%3.5M | 1,018.42%42.5M |
End cash Position | 84.27%2.98B | 84.27%2.98B | 45.06%2.38B | 13.05%2.54B | -37.32%1.96B | -40.35%1.62B | -40.35%1.62B | -44.62%1.64B | -4.53%2.24B | 6.00%3.13B |
Free cash flow | -121.82%-3.15B | -143.09%-1.12B | 27.63%-345.2M | -135.66%-867.7M | -612.71%-818.9M | -567.60%-1.42B | -300.35%-460M | -335.32%-477M | -47.28%-368.2M | -194.65%-114.9M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |